The Ledger

Centene will let more than 160,000 providers skip routine prior authorization starting in November, the largest insurer gold card announced so far. The insurer’s October 13 release, as published by Finviz from PR Newswire, names it the National Performance-Based Gold Card Program. It covers select outpatient services at launch, and providers who qualify submit a pre-notification instead of waiting for an authorization decision. Eligibility rests on approval track record, documentation quality and adherence to medical policy and regulatory rules; providers who do not qualify stay on standard review and can earn in later. Centene says it will expand to more services and providers over time and that the design drew on anonymous feedback from providers in 24 states. Per Healthcare Finance News, a supplemental source, participation is by invitation and eligibility is judged at the ordering provider’s tax ID level. Which services are covered, which lines of business apply, and any savings or denial-rate figure are not stated. Who it hits: physician groups and outpatient centers billing Centene, whose staff time on approvals could fall, and rival insurers now competing on prior authorization friction. The release page on Centene’s own site was not retrieved, so the specifics rest on wire copy. Confidence: High on the announced program; Low on its financial effect until Centene quantifies it.

MultiCare and Samaritan Health Services will combine November 1, adding five Oregon hospitals to a 13-hospital Washington system with a $700 million, 10-year capital pledge. Healthcare Dive, published October 14, reports that Oregon regulators approved the final piece, covering Samaritan’s health plans, the Friday before the announcement, after the Oregon Health Authority’s August approval, which Samaritan said came with conditions on access to care it did not list. Samaritan keeps its name and local governance, and MultiCare becomes its sole corporate member, per the Oregon Health Authority transaction summary as summarized in search results. The closing slipped from an earlier October 1 target. A Lincoln Chronicle report from June said Samaritan had to ask bondholders to waive a default notice tied to low reserves before the deal could proceed. Who it hits: independent rural and regional systems weighing the same trade of local control for capital, and the payers in Samaritan’s region. Confidence: High on the date and the investment pledge; Med on the bond history, which is local supplemental reporting.

The Trump administration ended Affordable Care Act (ACA) subsidies for about 189,000 Marketplace enrollees flagged as having duplicate Medicare, Medicaid or Children’s Health Insurance Program coverage, or as deceased, and says it prevents about $738 million in improper payments this year. Announced October 14, the action breaks down as roughly 120,000 duplicate Medicaid cases, 58,000 duplicate Medicare cases and about 14,500 deceased enrollees, per Healthcare Dive and AJMC, both supplemental; the HHS release was not retrieved. People flagged for duplicate coverage get 30 days to dispute or cancel the other coverage, and officials say no one loses existing Medicare or Medicaid. HHS Secretary Robert F. Kennedy Jr. acknowledged that a data match does not prove fraud. Who it hits: Marketplace insurers, whose membership and risk pool shrink further after the 18% individual market drop KFF reported this week, and navigators and brokers handling disputes. Confidence: Med, because the breakdown comes from press-conference remarks relayed by trade press.

THE DEAL SHEET

No other new transactions were spotted in the last 24 hours after scanning trade press and SEC filings. Deals announced earlier this week, including Labcorp and BioReference, Rush and Endeavor, and H1 and Defacto Health, ran in our October 16 issue.